Mechanistic analysis of transport through the mucus barrier
Mechanistic analysis of transport through the mucus barrier
批准号:
8613928
负责人:
Katharina Ribbeck
金额:
$32.89万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-30 至 2017-08-31
关键词:
AffectAnimalsBacteriaBacteriophagesBindingBiologicalCellsChargeChemical EngineeringChemicalsChemistryCommunicable DiseasesComplementComplexDiagnosticDrug Delivery SystemsDrug vehicleEngineeringExtracellular MatrixFingerprintGenesGoalsHIVHealthHuman PapillomavirusHydrogelsHydrophobicityIn VitroInterdisciplinary StudyKnowledgeLearningLengthLibrariesLifeMeasurableMeasuresMechanicsMicrofluidicsModelingMolecularMolecular ProfilingMucous body substanceMusNormal CellNuclear PoreNutrientOxygenPapillomavirusParticle SizeParticulatePenetrationPeptidesPhage DisplayPropertyProteinsProtocols documentationRoleScienceSpatial DistributionSurfaceSurface PropertiesSystemTestingTimeTissuesToxinTransport ProcessVaginaVirusWorkbaseclinical applicationcombinatorialdensitydesignimprovedin vivoinsightmacrophagenanoparticlenovel strategiesparticlepathogenpredictive modelingpreventprotein aminoacid sequencepublic health relevanceresearch studyscreeningsperm celltherapeutic vaccineuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The goal of this project is to gain deep mechanistic understanding and predictive capability of the molecular
mechanisms that govern transport through the mucus barrier. The mucus lining forms a selective barrier that
facilitates the uptake of nutrients, sperm, and oxygen, while preventing free passage of harmful viruses,
bacteria, and toxins. The detailed molecular properties that distinguish particles that pass through the mucus
barrier and particles that are rejected by the mucus barrier are largely unknown, and hence, predictive models
for mucosal transport are currently missing, despite their tremendous implications for drug delivery and
preventing prevalent infectious diseases (for example Papilloma virus, HIV). While the relevance of particle
size, net charge, and hydrophobicity for mucus transport has been studied in isolation, the effect of combining
these properties and the role of spatial arrangement have not been studied in a way that allows to predict
mucus-interactions or to design drug delivery vehicles with tailored mucus transport properties. We propose to
characterize molecular transport through the mucus barrier and relate the results to the spatial surface
arrangement of charge, hydrophobicity and specific peptide sequences. This knowledge will enable us to
determine biophysical fingerprints that are diagnostic for fast and slow passage, and has the potential to
transform the design of drug delivery vehicles as it will allow to combine surface functionalization (for tissue
targeting) while independently tuning the transport properties of a vehicle. In the first aim we will test the
influence of charge distribution and hydrophobicity for transport through mucus using short peptides with
systematically varied residues, and a microfluidic system to measure uptake, spatial distribution, and transport
through the mucus. In the second aim, we will use phage-display-based approaches to determine whether
these same rules, when applied to peptides on the surface of a particle (specifically, phage) can facilitate
passage of the particle through mucus. This system will also give insight into other parameters that affect
particle-mucus interactions, such as peptide length, specific residue sequence, surface display density, and
particle geometry. In Aim 3 we will integrate the knowledge from Aims 1 and 2 and determine the relevance of
surface charge, hydrophobicity, and specific peptide sequences influences mucus transport in vivo, using the
mouse vagina as a model. The multidisciplinary research team presents the expertise necessary for combining
fundamental science questions with cutting edge engineering applications: a biologist with experimental and
theoretical expertise in biological hydrogel systems, a mechanical engineer with expertise in transport
phenomena in biological tissues, a synthetic biologist with expertise in engineering phage display systems, and
a chemical engineer with expertise in controlled particle surface functionalization and characterization in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying mucin O-glycans in the regulation of Staphylococcus aureus pathogenesis
-
批准号:10617215
-
项目类别:
-
资助金额:$22.92万
-
财政年份:2022
-
负责人:Katharina Ribbeck
-
依托单位:
Identifying mucin O-glycans in the regulation of Staphylococcus aureus pathogenesis
-
批准号:10390851
-
项目类别:
-
资助金额:$20.42万
-
财政年份:2022
-
负责人:Katharina Ribbeck
-
依托单位:
Mucin Glycans in the Regulation of Microbial Virulence
-
批准号:10374060
-
项目类别:
-
资助金额:$56.89万
-
财政年份:2013
-
负责人:Katharina Ribbeck
-
依托单位:
Mucin Glycans in the Regulation of Microbial Virulence
-
批准号:9923034
-
项目类别:
-
资助金额:$56.89万
-
财政年份:2013
-
负责人:Katharina Ribbeck
-
依托单位:
Mechanistic analysis of transport through the mucus barrier
-
批准号:8739538
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2013
-
负责人:Katharina Ribbeck
-
依托单位:
Mechanistic analysis of transport through the mucus barrier
-
批准号:8925078
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2013
-
负责人:Katharina Ribbeck
-
依托单位:
海外基金